Crowley Elizabeth 4
4 · Celldex Therapeutics, Inc. · Filed Jun 3, 2024
Insider Transaction Report
Form 4
Crowley Elizabeth
SR. VP & CPDO
Transactions
- Exercise/Conversion
Common Stock
2024-05-30$2.78/sh+34,445$95,757→ 39,171 total - Exercise/Conversion
Common Stock
2024-05-30$9.02/sh+8,500$76,640→ 47,671 total - Exercise/Conversion
Incentive Stock Option (Right to Buy)
2024-05-30−34,445→ 0 totalExercise: $2.78Exp: 2029-06-19→ Common Stock (34,445 underlying) - Sale
Common Stock
2024-05-30$33.64/sh−38,597$1,298,384→ 9,074 total - Exercise/Conversion
Incentive Stock Option (Right to Buy)
2024-05-30−8,500→ 7,500 totalExercise: $9.02Exp: 2028-06-13→ Common Stock (8,500 underlying)
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.39 to $33.8934 per share, inclusive. The reporting person undertakes to provide to Celldex Therapeutics, Inc., any security holder of Celldex Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
- [F2]As of June 19, 2023, the option is fully vested.
- [F3]As of June 13, 2022, the option is fully vested.